[EN] SPIROCYCLIC MOLECULES AS MTH1 INHIBITORS<br/>[FR] MOLÉCULES SPIROCYCLIQUES SERVANT D'INHIBITEURS DE MTH1
申请人:WANG ZHAOYIN
公开号:WO2015172747A1
公开(公告)日:2015-11-19
Disclosed are spirocyclic compounds having MTH1 inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are useful for the treatment of abnormal cell growth, such as cancers.
[EN] 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS<br/>[FR] COMPOSÉS 1H-PYRAZOLO[4,3-D]PYRIMIDINE UTILES EN TANT QU'AGONISTES DU RÉCEPTEUR DE TYPE TOLL 7 (TLR7)
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2021154663A1
公开(公告)日:2021-08-05
Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). (I) Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
申请人:Wang Zhaoyin
公开号:US20140243303A1
公开(公告)日:2014-08-28
The present invention relates to spirocyclic compounds of formula I, namely spirocyclic (1H-pyrazol-4-yl)-3-(1-(2,6-dichloro-3-fiuorophenyl)ethoxy)pyridin-2-amines having protein kinase inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are c-Met and/or ALK inhibitors useful for the treatment of abnormal cell growth, such as cancers.
R
2
is selected from
[EN] ZESTE ENHANCER HOMOLOGUE 2 INHIBITOR AND USE THEREOF<br/>[FR] INHIBITEUR DE L'AMPLIFICATEUR DE L'HOMOLOGUE ZESTE 2 ET SON UTILISATION<br/>[ZH] ZESTE增强子同源物2抑制剂及其用途